Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Hartley

Showing results (51-60 of 52) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 52 results.
Ebiomedicine|August 23, 2018
IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem (NORDIL) study and the Integrated Imaging and Biomarker Study 3 (IBIS-3)Victor J van den Berg, Dorian O Haskard, Artur Fedorowski, et al.
Plos Medicine|February 22, 2022
Mortality risk prediction of high-sensitivity C-reactive protein in suspected acute coronary syndrome: A cohort studyAmit Kaura, Adam Hartley, Vasileios Panoulas, et al.
Pageof 6

Showing results (51-60 of 52) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 52 results.
Ebiomedicine|August 23, 2018
IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem (NORDIL) study and the Integrated Imaging and Biomarker Study 3 (IBIS-3)Victor J van den Berg, Dorian O Haskard, Artur Fedorowski, et al.
Plos Medicine|February 22, 2022
Mortality risk prediction of high-sensitivity C-reactive protein in suspected acute coronary syndrome: A cohort studyAmit Kaura, Adam Hartley, Vasileios Panoulas, et al.
Pageof 6